Efficacy of platinum in advanced triple-negative breast cancer with germline BRCA mutation determined by next generation sequencing.

objective
To compare the efficacy of platinum and non-platinum-based regimens as first-line treatment for triple-negative breast cancer is advanced (TNBC) and analyze the relationship between their success and status of the BRCA genes.


method
Retrospectively analyzed clinical data from 220 patients diagnosed with advanced pathological TNBC and treated in the Department of Breast Oncology, Peking University Cancer Hospital from 2013 to 2018 and evaluate the effectiveness of chemotherapy. A total of 114 patients had BRCA1 / 2 genes were tested by next generation sequencing (NGS) using peripheral blood, and we analyzed the correlation between efficacy and BRCA1 / 2 gene status.


result
non-platinum-based chemotherapy (NPCT) was given to 129 and platinum-based chemotherapy (PBCT) to 91 study patients. The level of clinical benefit (CBR) and median progression-free survival (PFS) were not statistically different between groups NPCT and PBCT. Overall average life (OS) was 30.0 and 22.5 months for PBCT and NPCT groups, respectively [P = 0.090, hazard ratio (HR) = 0.703]. BRCA status assessed 114 patients, 14 of whom have a detrimental germline BRCA1 / 2 (gBRCA) mutation (seven in each group). In PBCT group, CBR was 85.7% and 35.1% for patients with and without mutations that destroy gBRCA, respectively (P = 0.039). Median PFS was 14.9 and 5.3 months and the median OS was 26.5 and 15.5 months for patients with and without mutations that destroy gBRCA, respectively (P = 0.001, P = 0.161, respectively). Patients in group PBCT have significantly greater levels of grade 3-4 anemia (5.5% vs. 0%) and thrombocytopenia (8.8% vs 0%), while the palmar-plantar erythrodysesthesia (12.4% vs 0% ) and peripheral neuropathy (8.6% vs. 1.1%) occurred more frequently in the group NPCT.

Efficacy of platinum in advanced triple-negative breast cancer with germline BRCA mutation determined by next generation sequencing.
Efficacy of platinum in advanced triple-negative breast cancer with germline BRCA mutation determined by next generation sequencing.


conclusion
platinum-based regimen was more effective in patients with mutations gBRCA damage, but there was no difference in patients without BRCA gene mutation, so that the non-platinum is an option in patients without BRCA gene mutation consider the toxicity and side effects. And we suggest that patients with advanced TNBC must have a BRCA gene test.

TAME Hydrochloride

2050-500
EUR 338

Verapamil hydrochloride

2861-1G
EUR 131

Verapamil hydrochloride

2861-5G
EUR 327

Ticlopidine hydrochloride

2919-25
EUR 403

Ticlopidine hydrochloride

2919-5
EUR 153

EHNA hydrochloride

2265-25
EUR 283

EHNA hydrochloride

2265-5
EUR 115

AdipoRon hydrochloride

2572-25
EUR 588

AdipoRon hydrochloride

2572-5
EUR 185

Pargyline hydrochloride

2618-1000
EUR 175

Pargyline hydrochloride

2618-500
EUR 120

Clorgyline hydrochloride

2622-10
EUR 120

Clorgyline hydrochloride

2622-50
EUR 327

Clindamycin hydrochloride

2627-10
EUR 131

Clindamycin hydrochloride

2627-50
EUR 370

Loperamide hydrochloride

2683-1000
EUR 185

Loperamide hydrochloride

2683-500
EUR 131

Clonidine hydrochloride

2684-100
EUR 131

Clonidine hydrochloride

2684-500
EUR 359

Leelamine hydrochloride

2717-25
EUR 457

Leelamine hydrochloride

2717-5
EUR 153

SBE13 hydrochloride

2847-10
EUR 185

SBE13 hydrochloride

2847-50
EUR 588

Amodiaquine hydrochloride

A085-5G 5 g
EUR 55

Metformin, Hydrochloride

1691-5G
EUR 158

Irinotecan Hydrochloride

1752-250
EUR 387

Irinotecan Hydrochloride

1752-50
EUR 147

Epirubicin Hydrochloride

1753-25
EUR 457

Epirubicin Hydrochloride

1753-5
EUR 158

Gemcitabine Hydrochloride

1759-100
EUR 370

Gemcitabine Hydrochloride

1759-25
EUR 156

Amiodarone Hydrochloride

1828-100
EUR 126

Amiodarone Hydrochloride

1828-500
EUR 338

Phenformin hydrochloride

1889-100
EUR 115

Phenformin hydrochloride

1889-1000
EUR 359

Tomatidine hydrochloride

1893-25
EUR 137

Vancomycin Hydrochloride

B1507-1G
EUR 153

Vancomycin Hydrochloride

B1507-250
EUR 120

Vancomycin Hydrochloride

B1507-5G
EUR 262

Lincomycin Hydrochloride

B1524-1G
EUR 142

Lincomycin Hydrochloride

B1524-5G
EUR 403

Minocycline Hydrochloride

B1525-250
EUR 414

Minocycline Hydrochloride

B1525-50
EUR 142

Oxytetracycline Hydrochloride

B1527-25G
EUR 229

Oxytetracycline Hydrochloride

B1527-5G
EUR 109

Tetracycline Hydrochloride

B1535-10G
EUR 109

Tetracycline Hydrochloride

B1535-50G
EUR 196

Hydroxyfasudil Hydrochloride

B1559-25
EUR 631

Hydroxyfasudil Hydrochloride

B1559-5
EUR 196

Thioridazine Hydrochloride

B1581-1G
EUR 120

Thioridazine Hydrochloride

B1581-5G
EUR 327

Ivabradine Hydrochloride

B1595-10
EUR 142

Bendamustine Hydrochloride

B1596-25
EUR 457

Bendamustine Hydrochloride

B1596-5
EUR 153

Afuresertib hydrochloride

B1848-5
EUR 175

Chlorpromazine hydrochloride

B1992-100
EUR 120

Chlorpromazine hydrochloride

B1992-500
EUR 294

Triflupromazine hydrochloride

B1993-100
EUR 120

 ZLN024 hydrochloride

B2034-25
EUR 588

 ZLN024 hydrochloride

B2034-5
EUR 185

Topotecan hydrochloride

B2050-10
EUR 131

Givinostat hydrochloride

B2081-25
EUR 756

Givinostat hydrochloride

B2081-5
EUR 229

Moexipril hydrochloride

B2134-25
EUR 294

Imidapril hydrochloride

B2135-25
EUR 414

Imidapril hydrochloride

B2135-5
EUR 142

Benazepril hydrochloride

B2138-250
EUR 294

Benazepril hydrochloride

B2138-50
EUR 131

Dorzolamide hydrochloride

B2185-10
EUR 120

Dorzolamide hydrochloride

B2185-50
EUR 327

Eltoprazine hydrochloride

B2301-25
EUR 457

Eltoprazine hydrochloride

B2301-5
EUR 153

Papaverine hydrochloride

B2315-250
EUR 262

Papaverine hydrochloride

B2315-50
EUR 120

Sarecycline hydrochloride

B2383-25
EUR 588

Sarecycline hydrochloride

B2383-5
EUR 185

Sertraline (hydrochloride)

B2393-10
EUR 131

Sertraline (hydrochloride)

B2393-50
EUR 327

Migalastat hydrochloride

B2404-25
EUR 756

Migalastat hydrochloride

B2404-5
EUR 229

Butenafine hydrochloride

B2421-250
EUR 327

Butenafine hydrochloride

B2421-50
EUR 120

Naftifine hydrochloride

B2422-10
EUR 131

Naftifine hydrochloride

B2422-50
EUR 349

Rilpivirine hydrochloride

B2427-25
EUR 414

Rilpivirine hydrochloride

B2427-5
EUR 142

Tirabrutinib hydrochloride

B2556-25
EUR 457

Tirabrutinib hydrochloride

B2556-5
EUR 153

Robenidine hydrochloride

B2560-1G
EUR 131

Robenidine hydrochloride

B2560-5G
EUR 262

Sardomozide Hydrochloride

B2566-25
EUR 631

Sardomozide Hydrochloride

B2566-5
EUR 196

Riviciclib hydrochloride

B2567-1
EUR 142

Riviciclib hydrochloride

B2567-5
EUR 414

CPTH2 (hydrochloride)

B2815-1
EUR 120

CPTH2 (hydrochloride)

B2815-5
EUR 294

Resminostat (hydrochloride)

B2852-25
EUR 588

Resminostat (hydrochloride)

B2852-5
EUR 185

Leave a Comment